PaizaBio

PaizaBio is a US-based pharmaceutical contract manufacturing organization (CMO) producing sterile injectables drugs in China, for the Chinese market, to western standards of quality. We help western pharmaceutical companies quickly establish a manufacturing presence in China, providing aseptic fill-and-finish, lyophilization, packaging, and warehouse services. Partnering with PaizaBio, Western pharma companies minimize risk and cost as we have more than two decades of experience manufacturing drugs in China for the Chinese market. PaizaBio ensures complete transparency and accountability with BAO-Gong(TM), the industry's most comprehensive real-time remote manufacturing monitoring system. BAO-Gong provides digital and video tracking of each stage of manufacture and is accessible from anywhere in the world via Smartphone, tablet or laptop. We are also home to the Trans-Pacific Aseptic Institute of Training (TM), China's first "sterile university" dedicated to training the aseptic workforce. TPA-IT is located on our campus in Hangzhou, China, in greater metropolitan Shanghai. TAP-IT welcomes its inaugural class in March 2016. With 1.4 billion people, China's drug market is larger than North America, South America and the European Union combined. If you're a western pharma company, you need to be in China and PaizaBio will take you there.